查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941881

人體生長荷爾蒙市場規模、佔有率和趨勢分析報告：按產品類型、應用、給藥頻率、分銷管道、地區和細分市場預測（2026-2040 年）

Human Growth Hormone Market Size, Share & Trends Analysis Report By Product Type (Branded Products, Biosimilars), By Application, By Dosing Frequency, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2040
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

人體生長荷爾蒙概述

全球人體生長荷爾蒙市場規模預計2025年達到75.2億美元，預計2040年將達到284.1億美元。 2026年至2040年間，該市場預計將以8.52%的複合年成長率成長。人體生長荷爾蒙需求旺盛的主要原因是成人荷爾蒙缺乏症，尤其是生長激素缺乏症（GHD）。據估計，GHD的盛行率約為每萬人2-3例。

在成人中，生長激素缺乏症（GHD）可能由腦下垂體腫瘤、腦外傷或自然老齡化過程引起，導致一系列症狀，包括肌肉量減少、腹部脂肪堆積、骨骼密度下降、疲勞和代謝紊亂。由於這些症狀缺乏特異性，診斷常常被延誤，造成了巨大的未滿足醫療需求。這種未滿足的需求推動了人類生長激素（HGH）療法的引入，因為患者尋求治療以改善生活品質、控制代謝併發症並恢復荷爾蒙平衡。兒童生長遲緩，例如GHD引起的矮小症，仍然是人體生長荷爾蒙市場的主要驅動力。

人體生長荷爾蒙給藥和製劑方面的技術創新顯著提升了市場需求。重組人體生長荷爾蒙（rhGH）的研發已取代傳統的萃取方法療法，實現了更高的純度、更佳的安全性和更穩定的療效。這些進步拓展了HGH在兒童生長遲緩和成人荷爾蒙缺乏症治療中的應用，擴大了患者群體，並提高了整體治療接受度。長效HGH製劑和緩釋注射劑等最新創新透過減少給藥頻率提高了患者的便利性。這尤其改善了需要持續治療的成年患者的治療體驗，大大提高了HGH療法的接受度。此外，自動注射器和預填充注射筆的出現，使注射過程更加輕鬆便捷，從而提升了患者的接受度和滿意度。

製劑和給藥系統的技術創新是人體生長荷爾蒙市場成長的關鍵成長要素。專利趨勢清晰地表明，市場正朝著溫度穩定的製劑、緩釋系統以及無痛或非侵入性給藥方式發展。所有這些發展旨在減輕治療負擔、提高患者依從性並消除每日注射帶來的不便，最終帶來更好的臨床療效和更高的市場接受度。

專利反映出的一個總體趨勢是，研發投入不斷增加，旨在將人類生長激素（HGH）療法從每日注射轉變為長效、便捷且技術更先進的製劑。這些創新技術的商業化有望透過提高用藥依從性、減輕治療負擔以及支持高價策略，進一步擴大市場滲透率。隨著無針給藥方法、緩釋系統、微針平台和高穩定性製劑的持續發展，技術將繼續成為人體生長荷爾蒙市場的主要競爭驅動力。諸如EasyPod自動電子注射器等創新給藥系統的推出，顯著促進了人體生長荷爾蒙療法更易於獲得且更有效，並支持市場擴張。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：人體生長荷爾蒙市場的變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章：人體生長荷爾蒙市場：依產品類型分類的商業分析

  • 按產品類型分類的市場佔有率（2025 年和 2040 年）
  • 按產品類型分類的市場規模、預測和趨勢分析（2021-2040 年）
  • 品牌產品
  • 生物相似藥

第5章：人體生長荷爾蒙市場：按應用領域分類的商業分析

  • 按應用領域分類的市場佔有率（2025 年和 2040 年）
  • 按應用領域分類的市場規模、預測與趨勢分析（2021年至2040年）
  • 生長激素缺乏症（GHD）
  • 透納氏症
  • 原發性矮小症
  • 普拉德-威利症候群
  • 相對於胎齡而言的低出生體重（SGA）
  • 其他跡象

第6章：人體生長荷爾蒙市場：依給藥頻率分類的業務分析

  • 按給藥頻率分類的市場佔有率（2025 年和 2040 年）
  • 按給藥頻率分類的市場規模、預測和趨勢分析（2021-2040 年）
  • 每日注射生長激素
  • 每週注射一次生長激素

第7章：人體生長荷爾蒙市場：按分銷管道分類的業務分析

  • 按分銷管道分類的市場佔有率（2025 年和 2040 年）
  • 按分銷管道分類的市場規模、預測和趨勢分析（2021-2040 年）
  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 專科藥房

第8章：人體生長荷爾蒙市場：區域估算與趨勢分析

  • 區域市場佔有率分析（2025 年和 2040 年）
  • 區域市場概覽
  • 2021年至2040年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 參與公司概況
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/列表
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Ascendis Pharma A/S
    • Sandoz International GmbH（Novartis）
    • Merck KGaA/EMD Serono
    • Eli Lilly and Company
    • Ferring Pharmaceuticals
    • GeneScience Pharmaceuticals
    • Anhui Anke Biotechnology
    • LG Chem
Product Code: GVR-2-68038-057-6

Human Growth Hormone Summary

The global human growth hormone market size was estimated at USD 7.52 billion in 2025 and is projected to reach USD 28.41 billion by 2040, growing at a CAGR of 8.52% from 2026 to 2040. The main reason for the high demand of human growth hormone is adult hormone deficiency, especially Growth Hormone Deficiency (GHD). The estimated prevalence of GHD is approximately 2-3:10,000 population.

In adults, GHD may be caused by pituitary tumors, traumas to the brain, or natural aging processes, which in turn, produce a series of symptoms such as the loss of muscle mass, the distribution of fat towards the abdomen, decreased bone density, lethargy, and metabolic disturbances. The non-specific nature of these symptoms often delays diagnosis, creating a significant unmet medical need. This unmet need drives the adoption of HGH therapy, as patients seek treatment to improve quality of life, manage metabolic complications, and restore hormonal balance. Growth disorders in children, such as short stature due to GHD, remain a foundational driver of the human growth hormone market.

Technological innovations in human growth hormone delivery and formulation have significantly boosted market demand. The development of recombinant human growth hormone (rhGH) has replaced older extraction-based therapies, offering higher purity, improved safety, and consistent efficacy. These advances have expanded the therapeutic application of HGH in both pediatric growth disorders and adult hormone deficiencies, creating a larger patient base and increasing overall treatment adoption. Recent innovations such as long-acting HGH formulations and sustained-release injections have improved patient convenience by reducing the frequency of administration. The situation is improved for the patients, especially for the adults who need continuous treatment. Thus, the acceptance of HGH therapies is growing to a larger extent. Moreover, the auto-injectors and pre-filled pens have contributed to making the process of injections less painful and friendly, which in turn has positively affected the patients' acceptance and satisfaction.

The technological innovation regarding the formulation and delivery systems has been a significant growth driver in the Human Growth Hormone market. Patent activity clearly indicates a transformation towards temperature-stable formulations, sustained-release systems, and painless or non-invasive delivery methods. All these developments are intended to decrease the burden of treatment, boost patient adherence, and eliminate the daily injection-related difficulties, which in turn will lead to better clinical results and higher market acceptance.

The general trend reflected in the patents is that there is an increasing amount of R&D aimed at the transition of HGH therapy from daily injections to long-lasting, user-friendly, and technologically superior formats. The commercialization of these innovations will likely result in deeper market penetration through adherence enhancement, treatment burden reduction, and premium pricing support. The market of human growth hormones will continue to be driven by technology as the major competitive factor due to the ongoing developments in needle-free delivery, sustained-release systems, microneedle platforms, and high-stability formulations. The introduction of innovative delivery systems, such as the Easypod, an automated electronic injection device for growth hormone administration, has significantly contributed to the growth of the Human Growth Hormone market. These devices simplify the injection process, save patients' time, and reduce the risk of dosing errors, as the correct dose is programmed and verified by a healthcare professional. Such technological advancements enhance patient adherence and convenience, making HGH therapy more accessible and effective, thereby supporting market expansion.

Global Human Growth Hormone Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2040. For this study, Grand View Research has segmented the global human growth hormone market report based on product type, application, dosing frequency, distribution channel, and region:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2040)
  • Branded Products
    • Norditropin
    • Sogroya
    • Skytrofa
    • Ngenla
    • Other
  • Biosimilars
  • Application Outlook (Revenue, USD Million, 2021 - 2040)
  • Growth Hormone Deficiency (GHD)
    • Adult Growth Hormone Deficiency
    • Pediatric Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Small for Gestational Age (SGA)
  • Other Indications
  • Dosing Frequency Outlook (Revenue, USD Million, 2021 - 2040)
  • Daily hGH Injection
  • Weekly hGH Injection
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2040)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy
  • Regional Outlook (Revenue, USD Million, 2021 - 2040)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Application
    • 1.2.3. Dosing Frequency
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Human Growth Hormone Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Human Growth Hormone Market: Product Type Business Analysis

  • 4.1. Product Type Market Share, 2025 & 2040
  • 4.2. Product Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2021 to 2040 (USD Million)
  • 4.4. Branded Products
    • 4.4.1. Branded Products Market, 2021 - 2040 (USD Million)
    • 4.4.2. Norditropin
      • 4.4.2.1. Norditropin Market, 2021 - 2040 (USD Million)
    • 4.4.3. Sogroya
      • 4.4.3.1. Sogroya Market, 2021 - 2040 (USD Million)
    • 4.4.4. Skytrofa
      • 4.4.4.1. Skytrofa Market, 2021 - 2040 (USD Million)
    • 4.4.5. Ngenla
      • 4.4.5.1. Ngenla Market, 2021 - 2040 (USD Million)
    • 4.4.6. Other
      • 4.4.6.1. Other Market, 2021 - 2040 (USD Million)
  • 4.5. Biosimilars
    • 4.5.1. Biosimilars Market, 2021 - 2040 (USD Million)

Chapter 5. Human Growth Hormone Market: Application Business Analysis

  • 5.1. Application Market Share, 2025 & 2040
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2040 (USD Million)
  • 5.4. Growth Hormone Deficiency (GHD)
    • 5.4.1. Growth Hormone Deficiency (GHD) Market, 2021 - 2040 (USD Million)
    • 5.4.2. Adult Growth Hormone Deficiency
      • 5.4.2.1. Adult Growth Hormone Deficiency, 2021 - 2040 (USD Million)
    • 5.4.3. Pediatric Growth Hormone Deficiency
      • 5.4.3.1. Pediatric Growth Hormone Deficiency, 2021 - 2040 (USD Million)
  • 5.5. Turner Syndrome
    • 5.5.1. Turner Syndrome Market, 2021 - 2040 (USD Million)
  • 5.6. Idiopathic Short Stature
    • 5.6.1. Idiopathic Short Stature Market, 2021 - 2040 (USD Million)
  • 5.7. Prader-Willi Syndrome
    • 5.7.1. Prader-Willi Syndrome Market, 2021 - 2040 (USD Million)
  • 5.8. Small for Gestational Age (SGA)
    • 5.8.1. Small for Gestational Age (SGA) Market, 2021 - 2040 (USD Million)
  • 5.9. Other Indications
    • 5.9.1. Other Indications Market, 2021 - 2040 (USD Million)

Chapter 6. Human Growth Hormone Market: Dosing Frequency Business Analysis

  • 6.1. Dosing Frequency Market Share, 2025 & 2040
  • 6.2. Dosing Frequency Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Dosing Frequency, 2021 to 2040 (USD Million)
  • 6.4. Daily hGH Injection
    • 6.4.1. Daily hGH Injection Market, 2021 - 2040 (USD Million)
  • 6.5. Weekly hGH Injection
    • 6.5.1. Weekly hGH Injection Market, 2021 - 2040 (USD Million)

Chapter 7. Human Growth Hormone Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2040
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2040 (USD Million)
  • 7.4. Hospital Pharmacy
    • 7.4.1. Hospital Pharmacy Market, 2021 - 2040 (USD Million)
  • 7.5. Retail Pharmacy
    • 7.5.1. Retail Pharmacy Market, 2021 - 2040 (USD Million)
  • 7.6. Online Pharmacy
    • 7.6.1. Online Pharmacy Market, 2021 - 2040 (USD Million)
  • 7.7. Specialty Pharmacy
    • 7.7.1. Specialty Pharmacy Market, 2021 - 2040 (USD Million)

Chapter 8. Human Growth Hormone Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2040
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2040:
  • 8.4. North America
    • 8.4.1. North America Human Growth Hormone Market Estimates and Forecasts, By Country, 2021 - 2040 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Product Type Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Product Type Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. U.S. Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Product Type Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Product Type Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. Uk Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Product Type Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Product Type Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Product Type Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Product Type Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Product Type Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Product Type Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Product Type Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Product Type Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Product Type Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Product Type Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Product Type Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Product Type Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Product Type Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Product Type Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Japan Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Product Type Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. China Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Product Type Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Product Type Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Product Type Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Product Type Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Novo Nordisk A/S
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Pfizer Inc.
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Ascendis Pharma A/S
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Sandoz International GmbH (Novartis)
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Merck KGaA / EMD Serono
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Eli Lilly and Company
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Ferring Pharmaceuticals
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. GeneScience Pharmaceuticals
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Anhui Anke Biotechnology
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. LG Chem
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Growth Hormone market, by region, 2021 - 2040 (USD Million)
  • Table 4 Global Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 5 Global Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 6 Global Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 7 Global Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 8 North America Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 9 North America Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 10 North America Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 11 North America Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 12 North America Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 13 U.S. Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 14 U.S. Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 15 U.S. Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 16 U.S. Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 17 Canada Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 18 Canada Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 19 Canada Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 20 Canada Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 21 Mexico Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 22 Mexico Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 23 Mexico Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 24 Mexico Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 25 Europe Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 26 Europe Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 27 Europe Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 28 Europe Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 29 Europe Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 30 UK Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 31 UK Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 32 UK Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 33 UK Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 34 Germany Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 35 Germany Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 36 Germany Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 37 Germany Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 38 France Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 39 France Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 40 France Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 41 France Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 42 Italy Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 43 Italy Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 44 Italy Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 45 Italy Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 46 Spain Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 47 Spain Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 48 Spain Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 49 Spain Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 50 Norway Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 51 Norway Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 52 Norway Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 53 Norway Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 54 Denmark Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 55 Denmark Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 56 Denmark Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 57 Denmark Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 58 Sweden Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 59 Sweden Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 60 Sweden Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 61 Sweden Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 62 Asia Pacific Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 63 Asia Pacific Human Growth Hormone market, by product type, 2021 - 2040 (USD
  • Table 64 Asia Pacific Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 65 Asia Pacific Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 66 Asia Pacific Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 67 Japan Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 68 Japan Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 69 Japan Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 70 Japan Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 71 China Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 72 China Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 73 China Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 74 China Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 75 India Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 76 India Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 77 India Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 78 India Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 79 Australia Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 80 Australia Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 81 Australia Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 82 Australia Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 83 South Korea Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 84 South Korea Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 85 South Korea Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 86 South Korea Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 87 Thailand Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 88 Thailand Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 89 Thailand Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 90 Thailand Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 91 Latin America Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 92 Latin America Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 93 Latin America Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 94 Latin America Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 95 Latin America Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 96 Brazil Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 97 Brazil Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 98 Brazil Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 99 Brazil Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 100 Argentina Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 101 Argentina Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 102 Argentina Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 103 Argentina Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 104 Middle East & Africa Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 105 Middle East & Africa Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 106 Middle East & Africa Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 107 Middle East & Africa Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 108 Middle East & Africa Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 109 South Africa Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 110 South Africa Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 111 South Africa Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 112 South Africa Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 113 Saudi Arabia Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 114 Saudi Arabia Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 115 Saudi Arabia Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 116 Saudi Arabia Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 117 UAE Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 118 UAE Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 119 UAE Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 120 UAE Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 121 Kuwait Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 122 Kuwait Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 123 Kuwait Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 124 Kuwait Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)

List of Figures

  • Fig. 1 Human Growth Hormone market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Human Growth Hormone market dynamics
  • Fig. 11 Human Growth Hormone market: Porter's five forces analysis
  • Fig. 12 Human Growth Hormone market: PESTLE analysis
  • Fig. 13 Product Type market, 2021 - 2040 (USD Million)
  • Fig. 14 Branded Products market, 2021 - 2040 (USD Million)
  • Fig. 15 Norditropin market, 2021 - 2040 (USD Million)
  • Fig. 16 Sogroya market, 2021 - 2040 (USD Million)
  • Fig. 17 Skytrofa market, 2021 - 2040 (USD Million)
  • Fig. 18 Ngenlamarket, 2021 - 2040 (USD Million)
  • Fig. 19 Other market, 2021 - 2040 (USD Million)
  • Fig. 20 Biosimilars market, 2021 - 2040 (USD Million)
  • Fig. 21 Application market, 2021 - 2040 (USD Million)
  • Fig. 22 Growth Hormone Deficiency (GHD) market, 2021 - 2040 (USD Million)
  • Fig. 23 Adult Growth Hormone Deficiency market, 2021 - 2040 (USD Million)
  • Fig. 24 Pediatric Growth Hormone Deficiency market, 2021 - 2040 (USD Million)
  • Fig. 25 Turner Syndrome market, 2021 - 2040 (USD Million)
  • Fig. 26 Idiopathic Short Stature market, 2021 - 2040 (USD Million)
  • Fig. 27 Prader-Willi Syndrome market, 2021 - 2040 (USD Million)
  • Fig. 28 Small for Gestational Age (SGA) market, 2021 - 2040 (USD Million)
  • Fig. 29 Other Indications market, 2021 - 2040 (USD Million)
  • Fig. 30 Dosing Frequency market, 2021 - 2040 (USD Million)
  • Fig. 31 Daily hGH Injection market, 2021 - 2040 (USD Million)
  • Fig. 32 Weekly hGH Injection market, 2021 - 2040 (USD Million)
  • Fig. 33 Distribution Channel market, 2021 - 2040 (USD Million)
  • Fig. 34 Hospital Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 35 Retail Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 36 Online Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 37 Specialty Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 38 Human Growth Hormone market revenue, by region
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 North America Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 41 U.S. country dynamics
  • Fig. 42 U.S. Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 43 Canada country dynamics
  • Fig. 44 Canada Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 45 Mexico country dynamics
  • Fig. 46 Mexico Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 47 Europe Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 48 UK country dynamics
  • Fig. 49 UK Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 50 Germany country dynamics
  • Fig. 51 Germany Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 52 France country dynamics
  • Fig. 53 France Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 54 Italy country dynamics
  • Fig. 55 Italy Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 56 Spain country dynamics
  • Fig. 57 Spain Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 58 Norway country dynamics
  • Fig. 59 Norway Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 64 Asia Pacific Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 65 Japan country dynamics
  • Fig. 66 Japan Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 67 China country dynamics
  • Fig. 68 China Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 69 India country dynamics
  • Fig. 70 India Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 71 Australia country dynamics
  • Fig. 72 Australia Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 73 South Korea country dynamics
  • Fig. 74 South Korea Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 75 Thailand country dynamics
  • Fig. 76 Thailand Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 77 Latin America Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 78 Brazil country dynamics
  • Fig. 79 Brazil Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 80 Argentina country dynamics
  • Fig. 81 Argentina Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 82 MEA Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 83 South Africa country dynamics
  • Fig. 84 South Africa Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 85 Saudi Arabia country dynamics
  • Fig. 86 Saudi Arabia Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 87 UAE country dynamics
  • Fig. 88 UAE Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 89 Kuwait country dynamics
  • Fig. 90 Kuwait Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Company market position analysis
  • Fig. 93 Strategic framework